Vincent Sandanayaka
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$5.1MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $5.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 12, 2021 | NIH | SBIR Phase II Development of Tumor and Immuno-Metabolism Based Small Molecule Therapeutics for Refractory Breast Cancer | $855K | Nirogyone Therapeutics LLC |
| Sep 18, 2020 | NIH | SBIR Phase II Development of Tumor and Immuno-Metabolism Based Small Molecule Therapeutics for Refractory Breast Cancer | $1.1M | Nirogyone Therapeutics LLC |
| Sep 18, 2020 | NIH | SBIR Phase II Development of Tumor and Immuno-Metabolism Based Small Molecule Therapeutics for Refractory Breast Cancer | $2.0M | Nirogyone Therapeutics LLC |
| Sep 18, 2019 | NIH | SBIR Phase I TUMOR AND IMMUNO-METABOLISM BASED LACTATE TRANSPORTER INHIBITORs FOR METASTATIC MELANOMA | $292K | Nirogyone Therapeutics LLC |
| Sep 18, 2019 | NIH | SBIR Phase I TUMOR AND IMMUNO-METABOLISM BASED LACTATE TRANSPORTER INHIBITORs FOR METASTATIC MELANOMA | $292K | Nirogyone Therapeutics LLC |
| Aug 20, 2018 | NIH | SBIR Phase I INHIBITORS OF CELLULAR TRANSPORTERS FOR THE TREATMENT OF TNBC | $150K | Nirogyone Therapeutics LLC |
| Mar 15, 2018 | NIH | SBIR Phase I INHIBITORS OF CELLULAR TRANSPORTERS FOR THE TREATMENT OF TNBC | $50K | Nirogyone Therapeutics LLC |
| Sep 14, 2017 | NIH | SBIR Phase I INHIBITORS OF CELLULAR TRANSPORTERS FOR THE TREATMENT OF TNBC | $300K | Nirogyone Therapeutics LLC |
Peer ranks
Federal funding#267
Awards as PI#190
Patents#273
Companies
- Nirogyone Therapeutics LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.